Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer

British Journal of Radiology

Volumn 84, Issue 1006, 2011, Pages 903-918

  Harriss Phillips, W M ^a,b   Bezak, E ^a,b   Yeoh, E K ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CANCER GROWTH; CANCER RADIOTHERAPY; CELL DIVISION; CELL KILLING; HEAD AND NECK CANCER; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MONTE CARLO METHOD; RADIOBIOLOGY; REOXYGENATION; REVIEW; STEM CELL;

ALGORITHMS; ANOXIA; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; COMPUTER SIMULATION; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; OXYGEN; RADIOBIOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 80053082764     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/25012212     Document Type: Review

References (76)

1. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953;26:638-48.
2. Hill RP, Bush RS, Yeung P. The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. Br J Radiol 1971;44:299-304.
3. Wright EA, Howard-Flanders P. The influence of oxygen on the radiosensitivity of mammalian tissues. Acta radiol 1957;48:26-32.
4. Becker A, Hansgen G, BlochingM, Weigel C, Lautenschlager C, Dunst J. Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys 1998;42:35-41. (Pubitemid 28435593)
5. Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006;24:2098-104. (Pubitemid 46622121)
6. DinshawKA, Agarwal JP, Ghosh-Laskar S, Gupta T, Shrivastava SK. Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors. Clin Oncol (R Coll Radiol) 2006;18:383-9. (Pubitemid 44382294)
7. Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 2006;24:727-35. (Pubitemid 46622039)
8. Stadler P, Becker A, Feldmann HJ, Hansgen G, Dunst J, Wurschmidt F, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 1999;44:749-54. (Pubitemid 29284123)
9. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005;77:18-24. (Pubitemid 41503384)
10. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
11. Brenner DJ. Accelerated repopulation during radiotherapy: Quantitative evidence for delayed onset. Radiation Oncology Investigations 1993;1:167-72.
12. Marcu L, Van Doorn T, Olver I. Modelling of postirradiation accelerated repopulation in squamous cell carcinomas. Phys Med Biol 2004;49:3767-79. (Pubitemid 39206456)
13. Begg AC, Hofland I, Kummermehr J. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours. Eur J Cancer 1991;27:537-43.
14. Fowler JF. Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment - continually rapid proliferation unmasked. Radiother Oncol 1991;22:156-8.
15. Jones B, Dale RG. Cell loss factors and the linear-quadratic model. Radiother Oncol 1995;37:136-9.
16. Donaghey CE. CELLSIM and CELLGROW: tools for cell kinetic modeling. ISA Trans 1983;22:21-4. (Pubitemid 14503227)
17. Duchting W, Ginsberg T, Ulmer W. Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue. Stem Cells 1995;13:301-6.
18. Duchting W, Vogelsaenger T. Recent progress in modelling and simulation of three-dimensional tumor growth and treatment. Biosystems 1985;18:79-91. (Pubitemid 16253655)
19. Kocher M, Treuer H, Voges J, Hoevels M, Sturm V, Muller RP. Computer simulation of cytotoxic and vascular effects of radiosurgery in solid and necrotic brain metastases. Radiother Oncol 2000;54:149-56. (Pubitemid 30116766)
20. Smolle J, Stettner H. Computer simulation of tumour cell invasion by a stochastic growth model. J Theor Biol 1993;160:63-72.
21. Elkind MM, Swain RW, Alescio T, Sutton H, Moses WB. Oxygen, nitrogen, recovery and radiation therapy In: University of Texas, MD Anderson Hospital and Tumor Institute of Cellular Radiation Biology: A symposium considering radiation effects in the cell and possible implications for cancer therapy, a collection of papers 1965;442-61.
22. Tannock IF, Steel GG. Tumor growth and cell kinetics in chronically hypoxic animals. J Natl Cancer Inst 1970;45:123-33.
23. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-49.
24. Antipas VP, Stamatakos GS, Uzunoglu NK, Dionysiou DD, Dale RG. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration. Phys Med Biol 2004;49:1485-504. (Pubitemid 38578499)
25. Dionysiou DD, Stamatakos GS, Gintides D, Uzunoglu N, Kyriaki K. Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation. Open Biomed Eng J 2008;2:43-51.
26. Dionysiou DD, Stamatakos GS, Uzunoglu NK, Nikita KS, Marioli A. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation. J Theor Biol 2004;230:1-20. (Pubitemid 38951124)
27. Sovik A, Malinen E, Bruland OS, Bentzen SM, Olsen DR. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study. Phys Med Biol 2007;52:499-513. Epub 2006 Dec 29.
28. Stamatakos GS, Antipas VP, Uzunoglu NK, Dale RG. A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density. Br J Radiol 2006;79:389-400. (Pubitemid 43676342)
29. Tuckwell W, Bezak E, Yeoh E, Marcu L. Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer. Phys Med Biol 2008;53:4489-507.
30. Adam MF, Gabalski EC, Bloch DA, Oehlert JW, Brown JM, Elsaid AA, et al. Tissue oxygen distribution in head and neck cancer patients. Head Neck 1999;21:146-53. (Pubitemid 29096102)
31. 2 during accelerated radiotherapy of head and neck carcinoma. Eur J Cancer 1998;34:856-61.
32. Brown JM. The hypoxic cell: a target for selective cancer therapy - eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999;59:5863-70. (Pubitemid 30004940)
33. Zolzer F, Streffer C. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. Int J Radiat Oncol Biol Phys 2002;54:910-20.
34. Alarcon T, Byrne HM, Maini PK. A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells. J Theor Biol 2004;229:395-411. (Pubitemid 38844943)
35. Durand RE, Sham E. The lifetime of hypoxic human tumor cells. Int J Radiat Oncol Biol Phys 1998;42:711-5. (Pubitemid 28559403)
36. Marsaglia G, TsangWW. The Zigguratmethod for generating random variables. Journal of Statistical Software 2000;5:1-7.
37. Kirkpatrick JP, Cardenas-Navia LI, DewhirstMW. Predicting the effect of temporal variations in PO2 on tumor radiosensitivity. Int J Radiat Oncol Biol Phys 2004;59:822-33. (Pubitemid 38748748)
38. Ljungkvist AS, Bussink J, Rijken PF, Kaanders JH, Van der Kogel AJ, Denekamp J. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2002;54:215-28.
39. Armpilia CI, Dale RG, Jones B. Determination of the optimum dose per fraction in fractionated radiotherapy when there is delayed onset of tumour repopulation during treatment. Br J Radiol 2004;77:765-7. (Pubitemid 39386925)
40. Maciejewski B, Withers HR, Taylor JM, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 1989;16:831-43. (Pubitemid 19079722)
41. Tucker SL. Pitfalls in estimating the influence of overall treatment time on local tumor control. Acta Oncol 1999;38:171-8. (Pubitemid 29179771)
42. Fowler JF, Harari PM. Confirmation of improved localregional control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys 2000;48:3-6. (Pubitemid 30488206)
43. Begg AC, Haustermans K, Hart AA, Dische S, Saunders M, Zackrisson B, et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol 1999;50:13-23. (Pubitemid 29136733)
44. Mantel C, Hendrie P, Broxmeyer HE. Steel factor regulates cell cycle asymmetry. Stem Cells 2001;19:483-91. (Pubitemid 33095843)
45. Steel GG. Basic Clinical Radiobiology. 3 ed: Hodder Arnold, London, UK 2002.
46. Wilson GD, McNally NJ, Dische S, Saunders MI, Des Rochers C, Lewis AA, et al. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988;58:423-31. (Pubitemid 18267793)
47. Potten CS, Booth D, Cragg NJ, O'Shea JA, Tudor GL, Booth C. Cell kinetic studies in murine ventral tongue epithelium: cell cycle progression studies using double labelling techniques. Cell Prolif 2002;35 Suppl 1:16-21. (Pubitemid 34985144)
48. Ljungkvist AS, Bussink J, Kaanders JH, Rijken PF, Begg AC, Raleigh JA, et al. Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys 2005;62:1157-68. (Pubitemid 40884431)
49. Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer - the time factor. Int J Radiat Oncol Biol Phys 1997;39:831-6. (Pubitemid 27486070)
50. Terhaard CH, Kal HB, Hordijk GJ. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3. Int J Radiat Oncol Biol Phys 2005;62:62-9. (Pubitemid 40591924)
51. Trott KR. The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation. Acta Oncol 1999;38:153-7.
52. Trott KR, Kummermehr J. Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 1991;22:159-60.
53. Marcu L, Van Doorn T, Zavgorodni S, Olver I. Growth of a virtual tumour using probabilistic methods of cell generation. Australas Phys Eng Sci Med 2002;25:155-61. (Pubitemid 36204038)
54. Horiot J, Begg A, Le Fur R, Schraub S, Van den Bogaert W, Van Glabbeke M, et al. Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma. Recent Results Cancer Res 1994;134:111-9.
55. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997;37:259-67. (Pubitemid 27138707)
56. Chou SC, Azuma Y, Varia MA, Raleigh JA. Evidence that involucrin, amarker for differentiation, is oxygen regulated in human squamous cell carcinomas. Br J Cancer 2004;90:728-35. (Pubitemid 38297217)
57. Axelson H, Fredlund E, M. O, Landberg G, Påhlman S. Hypoxia-induced dedifferentiation of tumor cells - a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 2005;16:554-63. Epub 2005 Apr 26.
58. Bindra RS, Schaffer PJ, Meng A, Woo J, Maseide K, Roth ME, et al. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol 2004;24:8504-18. (Pubitemid 39245072)
59. Dale RG, Jones B. Radiobioloigcal Modelling in Radiation Oncology. London, UK: The British Intistitue of Radiology; 2007.
60. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 2004;59:242-9. (Pubitemid 38501529)
61. Tucker SL, Chan KS. The selection of patients for accelerated radiotherapy on the basis of tumor growth kinetics and intrinsic radiosensitivity. Radiother Oncol 1990;18:197-211. (Pubitemid 20221781)
62. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36. (Pubitemid 27345199)
63. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16. (Pubitemid 30488207)
64. Hliniak A, Gwiazdowska. B, Szutkowski. Z. A multicentre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time. Radiother Oncol 2002;62:1-10. (Pubitemid 34121944)
65. Pinto LH, Canary PC, Araujo CM, Bacelar SC, Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:557-62.
66. Overgaard J, Alsner J, Eriksen J, Horsman MR, Grau C. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. Rays 2000;25:313-9.
67. Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. J Clin Oncol 2006;24:2873-8. (Pubitemid 46630588)
68. Scott OC. Mathematical models of repopulation and reoxygenation in radiotherapy. Br J Radiol 1990;63:821-3. (Pubitemid 20333672)
69. Antognoni P, Bignardi M, Cazzaniga LF, Poli AM, Richetti A, Bossi A, et al. Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics - a phase II multicenter study. Int J Radiat Oncol Biol Phys 1996; 36:1137-45. (Pubitemid 27014500)
70. Horiot JC, Bontemps P, Van den Bogaert W, Le Fur R, Van den Weijngaert D, Bolla M, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111-21. (Pubitemid 27345198)
71. Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 2004;59:743-51. (Pubitemid 38748739)
72. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988;14:831-8.
73. Lehtio K, Eskola O, Viljanen T, Oikonen V, Gronroos T, Sillanmaki L, et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:971-82. (Pubitemid 38834289)
74. Nordsmark M, Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 2004;43:396-403. (Pubitemid 38887861)
75. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9. (Pubitemid 26396294)
76. Dorr W. Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions. Int J Radiat Biol 1997;72:635-43. (Pubitemid 28020327)